Search results for Emicizumab
Emicizumab Biosimilar – Anti-F10, F9 activated form mAb – Research Grade, ProteoGenix, PX-TA1394
Description of Emicizumab Biosimilar - Anti-F10, F9 activated form mAb - Research Grade General information on Anti-F10/F9 activated form[Homo sapiens] (Emicizumab) Monoclonal Antibody Emicizumab is a humanized monoclonal antibody that mimics the function of coagulation factor VIII and has the ability to simultaneously bind to activated factors IX and X.
Host
Reactivity
Applications
Conjugation
Emicizumab, Abbexa, abx831353
Emicizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting F10/F9 activated form, for use in laboratory research applications. This product is not suitable for use as medicines or in Human, therapeutic or diagnostic applications.
Host
Mammalian cells
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated
Emicizumab Biosimilar - Research Grade, ichor.bio, ICH5178
Detects human Factor IX and Factor X
Host
CHO Cells
Reactivity
Human
Applications
Conjugation
Research Grade Emicizumab (HF610016), abinScience, HF610016
Host
Humanized
Reactivity
Human
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Conjugation
Please provide the required information below so that we can quickly source your products.